REMS programs need to address stakeholder usability
Heather Morel
Advertisement
Articles by Heather Morel
Five steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations
Advertisement
Latest Updated Articles
- Dealing With REMS Challenges in Drug Commercialization
Published: August 19th 2009 | Updated:
- Smoothing the Path to Drug Safety
Published: June 28th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
US News & World Report Reveals 2026 Best Medicare Advantage and Part D Companies
2
Cold Chain Technologies, Teva, and Kuehne+Nagel Proves Sea Freight Viable for High-Value Pharma Shipments
3
HDA 2025 Traceability Seminar: Pharma Supply Chain Nears Full DSCSA Compliance
4
AstraZeneca Expands Texas Manufacturing Facility to Double Production of Hyperkalemia Drug
5
